CXCL9 and breast neoplasm: Notably, the C-X-C motif chemokine ligand 9/10/11 (CXCL9/10/11)- C-X-C motif chemokine receptor 3 axis, which relies on IFN-γ activity, is highly expresse in primary breast tumors from patients with subsequent brain metastases.